Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in China and Korea

Journal of Gastric Cancer

Volumn 15, Issue 1, 2015, Pages 19-28

  Shen, Zhan Long ^a   Song, Kyo Young ^b   Ye, Ying Jiang ^a   Xie, Qi Wei ^a   Liang, Bin ^a   Jiang, Kewei ^a   Park, Cho Hyun ^b   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b The Catholic University of Korea   (South Korea)

Author keywords

China; Clinicopathological characteristics; Korea; Stomach neoplasms; Survival

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHINA; ESOPHAGUS TUMOR; FEMALE; GASTRECTOMY; HUMAN; KAPLAN MEIER METHOD; KOREA; LONG TERM SURVIVAL; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATHOLOGY; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; STOMACH CANCER; TUMOR INVASION;

EID: 84961378104     PISSN: 2093582X     EISSN: 20935641     Source Type: Journal    
DOI: 10.5230/jgc.2015.15.1.19     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Erratum: global cancer statistics. CA Cancer J Clin 2011;61:134.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044.
3. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006;55:1545-1552.
4. Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer 2011;11:135-140.
5. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006;12:17-20.
6. Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol 2002;28:214-219.
7. Yao JC, Schnirer II, Reddy S, Chiang S, Najam A, Yu C, et al. Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer 2002;5:208-212.
8. Bickenbach K, Strong VE. Comparisons of gastric cancer treatments: East vs. West. J Gastric Cancer 2012;12:55-62.
9. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg 2000;232: 362-371.
10. Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg 2000;66:821-826.
11. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol 2013;43:492-507.
12. Mok YJ, Koo BW, Whang CW, Kim SM, Maruyama K, Sasako M, et al. Cancer of the stomach: a review of two hospitals in Korea and Japan. World J Surg 1993;17:777-782.
13. Nakajima S. Gastric cancer screening in Japan, now and tomorrow. Nihon Rinsho 2012;70:1686-1693.
14. Tokunaga M, Sano T, Ohyama S, Hiki N, Fukunaga T, Yamada K, et al. Clinicopathological characteristics and survival difference between gastric stump carcinoma and primary upper third gastric cancer. J Gastrointest Surg 2013;17:313-318.
15. Yu M, Zheng HC, Xia P, Takahashi H, Masuda S, Takano Y, et al. Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res 2010;132:295-302.
16. Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol 2008;38:327-333.
17. Kim Y, Jun JK, Choi KS, Lee HY, Park EC. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 2011;12:725-730.
18. Choi KS, Jun JK, Lee HY, Park S, Jung KW, Han MA, et al. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci 2011;102:1559-1564.
19. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19.
20. Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer. Acta Biomed 2006;77:118-123.
21. Gonzalez CA. Nutrition and cancer: the current epidemiological evidence. Br J Nutr 2006;96 Suppl 1:S42-S45.
22. Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol 2008;34:36-41.
23. Hasegawa S, Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg 2009;33:95-103.
24. Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification. Dis Esophagus 2009;22:676-681.
25. Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg 2011;396:615-623.
26. Kosaka T, Usami K, Ueshige N, Hasegawa T, Yoshitani S, Sugaya J, et al. Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases. Hepatogastroenterology 2006;53:629-633.
27. Maeta M, Yamashiro H, Saito H, Katano K, Kondo A, Tsujitani S, et al. A prospective pilot study of extended (D3) and super- extended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 1999;125:325-331.
28. Hu JK, Yang K, Zhang B, Chen XZ, Chen ZX, Chen JP. D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today 2009;39:207-213.
29. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al; Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-462.
30. An JY, Pak KH, Inaba K, Cheong JH, Hyung WJ, Noh SH. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg 2011;98:667-672.
31. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol 2007;14:317-328.
32. Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One 2012;7:e49424.
33. Lee SR, Kim HO, Son BH, Shin JH, Yoo CH. Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg 2012;36:1096-1101.